Engineering CAR-T cells

Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients’ or donors’ blood. After the T c...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Biomarker research Ročník 5; číslo 1; s. 22 - 6
Hlavní autori: Zhang, Cheng, Liu, Jun, Zhong, Jiang F., Zhang, Xi
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London BioMed Central 24.06.2017
BioMed Central Ltd
Springer Nature B.V
BMC
Predmet:
ISSN:2050-7771, 2050-7771
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients’ or donors’ blood. After the T cells are expanded and genetically modified, they are reinfused into the patients. However, many challenges still need to be resolved in order for this technology to gain widespread adoption. In this review, we first discuss the structure and evolution of chimeric antigen receptors. We then report on the tools used for production of CAR-T cells. Finally, we address the challenges posed by CAR-T cells.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:2050-7771
2050-7771
DOI:10.1186/s40364-017-0102-y